Cargando…
Anticholinesterase Activity of Budmunchiamine Alkaloids Revealed by Comparative Chemical Profiling of Two Albizia spp., Molecular Docking and Dynamic Studies
Alzheimer’s disease remains a global health challenge and an unmet need requiring innovative approaches to discover new drugs. The current study aimed to investigate the inhibitory activity of Albizia lucidior and Albizia procera leaves against acetylcholinesterase enzyme in vitro and explore their...
Autores principales: | Hussein, Mai E., Mohamed, Osama G., El-Fishawy, Ahlam M., El-Askary, Hesham I., Hamed, Ahmed A., Abdel-Aziz, Marwa M., Alnajjar, Radwan, Belal, Amany, Naglah, Ahmed M., Almehizia, Abdulrahman A., Al-Karmalawy, Ahmed A., Tripathi, Ashootosh, El Senousy, Amira S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738009/ https://www.ncbi.nlm.nih.gov/pubmed/36501324 http://dx.doi.org/10.3390/plants11233286 |
Ejemplares similares
-
Identification of Antibacterial Metabolites from Endophytic Fungus Aspergillus fumigatus, Isolated from Albizia lucidior Leaves (Fabaceae), Utilizing Metabolomic and Molecular Docking Techniques
por: Hussein, Mai E., et al.
Publicado: (2022) -
Evaluation of some pharmacological activities of Budmunchiamine - A isolated from Albizia amara
por: Thippeswamy, Sreerangegowda, et al.
Publicado: (2015) -
Secondary metabolites and bioactivities of Albizia anthelmintica
por: Mohamed, Tahia K., et al.
Publicado: (2013) -
Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease
por: Alnajjar, Radwan, et al.
Publicado: (2020) -
Anticoagulants as Potential SARS-CoV-2 M(pro) Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
por: Abo Elmaaty, Ayman, et al.
Publicado: (2022)